ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,619,212 | +269.7% | 1,037,282 | +318.3% | 0.22% | +263.3% |
| Q2 2023 | $5,036,880 | -79.7% | 248,000 | -79.4% | 0.06% | -81.9% |
| Q4 2022 | $24,839,782 | +201.1% | 1,201,150 | +359.5% | 0.33% | +147.8% |
| Q1 2022 | $8,250,000 | -88.1% | 261,419 | -84.7% | 0.13% | -86.5% |
| Q4 2021 | $69,059,000 | +16.6% | 1,706,425 | +0.4% | 0.99% | +2.3% |
| Q3 2021 | $59,248,000 | +29.7% | 1,699,113 | +2.1% | 0.97% | +13.5% |
| Q2 2021 | $45,682,000 | +31.4% | 1,663,568 | +34.4% | 0.85% | +10.5% |
| Q1 2021 | $34,755,000 | +2442.4% | 1,237,730 | +1156.4% | 0.77% | +686.7% |
| Q1 2020 | $1,367,000 | – | 98,516 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $65,241,000 | 19.83% |
| Octagon Capital Advisors LP | 2,095,231 | $84,794,000 | 16.50% |
| EcoR1 Capital, LLC | 5,523,358 | $223,530,000 | 7.12% |
| BVF INC/IL | 3,398,067 | $137,520,000 | 4.99% |
| PFM Health Sciences, LP | 3,431,010 | $138,853,000 | 4.73% |
| Alphabet Inc. | 2,563,441 | $103,742,000 | 2.50% |
| Boxer Capital, LLC | 1,432,200 | $57,961,000 | 2.25% |
| PARK CIRCLE Co | 64,000 | $2,590,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 283,210 | $11,462,000 | 1.72% |
| DAFNA Capital Management LLC | 117,200 | $4,743,000 | 1.19% |